-
1دورية أكاديمية
المؤلفون: Nash, Peter, Kerschbaumer, Andreas, Dörner, Thomas, Dougados, Maxime, Fleischmann, Roy M, Geissler, Klaus, McInnes, Iain, Pope, Janet E, van der Heijde, Désirée, Stoffer-Marx, Michaela, Takeuchi, Tsutomu, Trauner, Michael, Winthrop, Kevin L, de Wit, Maarten, Aletaha, Daniel, Baraliakos, Xenofon, Boehncke, Wolf-Henning, Emery, Paul, Isaacs, John D, Kremer, Joel, Lee, Eun Bong, Maksymowych, Walter P, Voshaar, Marieke, Tam, Lai-Shan, Tanaka, Yoshiya, van den Bosch, Filip, Westhovens, René, Xavier, Ricardo, Smolen, Josef S
المصدر: ISSN: 0003-4967 ; Annals of the Rheumatic Diseases, vol. 80, no. 1 (2021) p. 71-87.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Adamantane/analogs & derivatives/therapeutic use, Advisory Committees, Antirheumatic Agents/therapeutic use, Arthritis, Psoriatic/drug therapy/immunology, Rheumatoid/drug therapy/immunology, Azetidines/therapeutic use, Cytokines/immunology, Drug Therapy, Combination, Europe, Heterocyclic Compounds, 3-Ring/therapeutic use, Humans, Inflammatory Bowel Diseases/drug therapy/immunology, Janus Kinase Inhibitors/therapeutic use, Niacinamide/analogs & derivatives/therapeutic use, Piperidines/therapeutic use, Psoriasis/drug therapy/immunology, Purines/therapeutic use, Pyrazoles/therapeutic use, Pyridines/therapeutic use, Pyrimidines/therapeutic use, Rheumatology, Spondylarthropathies/drug therapy/immunology, Spondylitis, Ankylosing/drug therapy/immunology, Sulfonamides/therapeutic use, Triazoles/therapeutic use
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33158881; https://archive-ouverte.unige.ch/unige:154811Test; unige:154811
-
2دورية أكاديمية
المؤلفون: Ryom, L., Cotter, A., De Miguel, R., Béguelin, C., Podlekareva, D., Arribas, J.R., Marzolini, C., Mallon, P., Rauch, A., Kirk, O., Molina, J.M., Guaraldi, G., Winston, A., Bhagani, S., Cinque, P., Kowalska, J.D., Collins, S., Battegay, M.
المساهمون: EACS Governing Board, De Miguel Buckley, R., d'Arminio Monforte, A., Bracchi, M., Dedes, N., Horban, A., Katlama, C., Latysheva, I., Lundgren, J.D., McCormack, S., Mussini, C., Pozniak, A., Pulido, F., Raffi, F., Reiss, P., Stellbrink, H.J., Vasylyev, M., Gibbons, S., Livio, F., Behrens, G., Bower, M., Compston, J., De Wit, S., Fabbri, L.M., Fux, C.A., Gisslen, M., Martínez, E., Miro, J.M., Negredo, E., Poulter, N., Sebastiani, G., Berenguer, J., Boesecke, C., Bruno, R., Konov, S., Lacombe, K., Mauss, S., Mendão, L., Peters, L., Puoti, M., Rockstroh, J.K., Ambrosioni, J., De Castro, N., Fätkenheuer, G., Furrer, H., Oprea, C., Volny-Anne, A., Sullivan, A., Mulcahy, F., Wensing, A.
المصدر: HIV medicine, vol. 21, no. 10, pp. 617-624
مصطلحات موضوعية: Age Factors, Anti-Retroviral Agents/therapeutic use, Comorbidity, Drug Interactions, Drug Therapy, Combination, HIV Infections/drug therapy, HIV Integrase Inhibitors/therapeutic use, Heterocyclic Compounds, 3-Ring/therapeutic use, Humans, Lamivudine/therapeutic use, Oxazines/therapeutic use, Piperazines/therapeutic use, Pyridones/therapeutic use, Treatment Outcome, Triazoles/therapeutic use, European AIDS Clinical Society (EACS) Guidelines, HIV, antiretroviral treatment, comorbidities, drug-drug interactions, hepatitis B virus, hepatitis C virus, opportunistic infections, prescribing in elderly patients
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32885559; info:eu-repo/semantics/altIdentifier/eissn/1468-1293; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0A40744EDF846; https://serval.unil.ch/notice/serval:BIB_0A40744EDF84Test; urn:issn:1464-2662; https://serval.unil.ch/resource/serval:BIB_0A40744EDF84.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0A40744EDF846Test
الإتاحة: https://doi.org/10.1111/hiv.12878Test
https://serval.unil.ch/notice/serval:BIB_0A40744EDF84Test
https://serval.unil.ch/resource/serval:BIB_0A40744EDF84.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0A40744EDF846Test -
3دورية أكاديمية
المؤلفون: Stader, F., Decosterd, L., Stoeckle, M., Cavassini, M., Battegay, M., Saldanha, S.A., Marzolini, C., Courlet, P.
المساهمون: and the Swiss HIV Cohort Study
المصدر: AIDS, vol. 34, no. 6, pp. 949-952
مصطلحات موضوعية: Aged, 80 and over, Aging, Amlodipine/adverse effects, Amlodipine/therapeutic use, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active, Atorvastatin/adverse effects, Atorvastatin/therapeutic use, Cardiovascular Agents/adverse effects, Cardiovascular Agents/therapeutic use, Cardiovascular Diseases/drug therapy, Cardiovascular Diseases/epidemiology, Darunavir/adverse effects, Darunavir/therapeutic use, Drug Interactions, Female, HIV Infections/drug therapy, HIV Infections/epidemiology, Heterocyclic Compounds, 3-Ring/adverse effects, 3-Ring/therapeutic use, Humans, Male, Middle Aged, Oxazines/adverse effects, Oxazines/therapeutic use, Piperazines/adverse effects, Piperazines/therapeutic use
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32028327; info:eu-repo/semantics/altIdentifier/eissn/1473-5571; https://serval.unil.ch/notice/serval:BIB_6666EE49EABDTest; urn:issn:0269-9370
الإتاحة: https://doi.org/10.1097/QAD.0000000000002489Test
https://serval.unil.ch/notice/serval:BIB_6666EE49EABDTest -
4دورية أكاديمية
المؤلفون: Stader, F., Courlet, P., Decosterd, L.A., Battegay, M., Marzolini, C.
المصدر: Clinical pharmacology and therapeutics, vol. 109, no. 4, pp. 1025-1029
مصطلحات موضوعية: Adult, Aged, 80 and over, Aging/physiology, Amides/pharmacokinetics, Amides/therapeutic use, Anti-Retroviral Agents/pharmacokinetics, Anti-Retroviral Agents/therapeutic use, Area Under Curve, Drug Monitoring, Female, HIV Infections/drug therapy, HIV Integrase Inhibitors/pharmacokinetics, HIV Integrase Inhibitors/therapeutic use, Heterocyclic Compounds, 3-Ring/pharmacokinetics, 3-Ring/therapeutic use, Humans, Male, Metabolic Clearance Rate, Middle Aged, Models, Biological, Piperazines/pharmacokinetics, Piperazines/therapeutic use, Pyridones/pharmacokinetics, Pyridones/therapeutic use, Switzerland, Young Adult
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33521960; info:eu-repo/semantics/altIdentifier/eissn/1532-6535; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_04518947F8534; https://serval.unil.ch/notice/serval:BIB_04518947F853Test; urn:issn:0009-9236; https://serval.unil.ch/resource/serval:BIB_04518947F853.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_04518947F8534Test
الإتاحة: https://doi.org/10.1002/cpt.2178Test
https://serval.unil.ch/notice/serval:BIB_04518947F853Test
https://serval.unil.ch/resource/serval:BIB_04518947F853.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_04518947F8534Test -
5دورية أكاديمية
المصدر: 2019 , ' Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy : Results from a randomised clinical trial ' , International Journal of Antimicrobial Agents , vol. 54 , no. 5 , pp. 592-600 . https://doi.org/10.1016/j.ijantimicag.2019.08.001Test
مصطلحات موضوعية: Antiretroviral Therapy, Highly Active, Antirheumatic Agents/therapeutic use, Auranofin/therapeutic use, CD4 Lymphocyte Count, DNA, Viral/drug effects, HIV Fusion Inhibitors/therapeutic use, HIV Infections/drug therapy, HIV Integrase Inhibitors/therapeutic use, HIV-1/drug effects, Heterocyclic Compounds, 3-Ring/therapeutic use, Humans, Maraviroc/therapeutic use, Oxazines, Piperazines, Proviruses/drug effects, Pyridones, Virus Latency/drug effects
الإتاحة: https://doi.org/10.1016/j.ijantimicag.2019.08.001Test
https://hdl.handle.net/1983/d4e3ba17-387b-497a-9039-b3ab59c421ccTest
https://research-information.bris.ac.uk/en/publications/d4e3ba17-387b-497a-9039-b3ab59c421ccTest -
6دورية أكاديمية
المؤلفون: Chtioui, H., Buclin, T., Moradpour, D.
المصدر: Revue Médicale Suisse, vol. 10, no. 440, pp. 1600-4, 1606
مصطلحات موضوعية: Antiviral Agents/pharmacology, Antiviral Agents/therapeutic use, Drug Interactions, Hepatitis C, Chronic/drug therapy, Heterocyclic Compounds, 3-Ring/pharmacology, 3-Ring/therapeutic use, Humans, Imidazoles/pharmacology, Imidazoles/therapeutic use, Protease Inhibitors/pharmacology, Protease Inhibitors/therapeutic use, Sulfonamides/pharmacology, Sulfonamides/therapeutic use, Uridine Monophosphate/analogs & derivatives, Uridine Monophosphate/pharmacology, Viral Nonstructural Proteins/antagonists & inhibitors
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25276998; info:eu-repo/semantics/altIdentifier/pissn/1660-9379; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_137CFB3E09106; https://serval.unil.ch/notice/serval:BIB_137CFB3E0910Test; urn:issn:1660-9379; https://serval.unil.ch/resource/serval:BIB_137CFB3E0910.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_137CFB3E09106Test
النص الكامل